List of works - G Paul Amminger

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

scientific article published on 20 March 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

scientific article

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

scientific article

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

scientific article published on 6 August 2016

Affect recognition and functioning in putatively prodromal individuals.

scientific article published on 9 May 2013

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

scientific article published on 03 January 2007

Are current labeling terms suitable for people who are at risk of psychosis?

scientific article published on 20 January 2017

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

scientific article published on 26 January 2015

Back to the future: predicting and reshaping the course of psychotic disorder

scientific article published on January 2008

Biomarkers and clinical staging in psychiatry

scientific article

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

scientific article

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

scientific article published on 28 November 2018

Clinical trajectories in the ultra-high risk for psychosis population

scientific article published on 18 February 2018

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

scientific article published on 11 March 2020

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

scientific article published on 27 May 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

scientific article published on 10 July 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

scientific article published on 10 June 2020

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

scientific article published on 19 October 2018

Delayed sleep onset in depressed young people.

scientific article

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

scientific article published on 28 March 2014

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

scientific article published on 26 August 2020

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

scientific article published on May 2009

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

scientific article

Dr McGorry and colleagues reply.

scientific article

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

scientific article published on 25 July 2020

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

scientific article published on 15 June 2013

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

scientific article

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

scientific article published on 16 February 2014

Emotion recognition in individuals at clinical high-risk for schizophrenia.

scientific article

Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

scientific article

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

scientific article published in April 2018

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

scientific article published in June 2012

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

scientific article published on 06 February 2019

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

scientific article published on 07 May 2019

Global research priorities for youth mental health

scientific article published on 01 February 2020

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

scientific article published on 30 December 2015

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

scientific article

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

scientific article published on 01 January 2022

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

scientific article published on 10 November 2017

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

scientific article published on 30 June 2009

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

scientific article published in August 2013

Metabolic changes in first‐episode early‐onset schizophrenia with second‐generation antipsychotics ⬇️

scientific article published on August 22, 2013

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

scientific article published on 16 August 2015

Negative Psychosis Prevention Trials-Reply

scientific article

Negative and Positive Dimensions of Schizotypal Personality Disorder

scientific article published on January 1, 1997

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

scientific article published on 14 December 2018

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study.

scientific article

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS.

scientific article

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

scientific article

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

scientific article published in July 2013

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

scientific article published on 06 September 2020

Online and social networking interventions for the treatment of depression in young people: a systematic review

scientific article

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

scientific article

PACE: a specialised service for young people at risk of psychotic disorders

scientific article published in October 2007

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.

scientific article published on 27 May 2016

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

scientific article

Premorbid adjustment and remission of positive symptoms in first-episode psychosis ⬇️

scientific article published on December 1, 1997

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

scientific article

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis

scientific article published on 19 October 2010

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

scientific article published in September 2009

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

scientific article published on 6 June 2019

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

scientific article published on 16 October 2018

Review: limited evidence from two small trials suggests no improvement in ASD symptoms with short term ω-3 supplementation ⬇️

scientific article published on 02 March 2012

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

scientific article

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

scientific article

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

scientific article published on 02 March 2013

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

scientific article published on 05 September 2012

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

scientific article

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

scientific article

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

scientific article published on 09 October 2019

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

scientific article

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

scientific article

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

scientific article published on 18 September 2019

The New York high-risk project: social and general intelligence in children at risk for schizophrenia ⬇️

scientific article published on May 4, 1998

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

scientific article

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

scientific article

Whither the attenuated psychosis syndrome?

scientific article

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.

scientific article published on 13 August 2014

List of works by G Paul Amminger

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

Affect recognition and functioning in putatively prodromal individuals.

Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis

Are current labeling terms suitable for people who are at risk of psychosis?

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

Back to the future: predicting and reshaping the course of psychotic disorder

Biomarkers and clinical staging in psychiatry

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance

Clinical trajectories in the ultra-high risk for psychosis population

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

Delayed sleep onset in depressed young people.

Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

Dr McGorry and colleagues reply.

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

Emotion recognition in individuals at clinical high-risk for schizophrenia.

Erratum to: A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study

Global research priorities for youth mental health

Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

Metabolic changes in first‐episode early‐onset schizophrenia with second‐generation antipsychotics ⬇️

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Negative Psychosis Prevention Trials-Reply

Negative and Positive Dimensions of Schizotypal Personality Disorder

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study.

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS.

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

Online and social networking interventions for the treatment of depression in young people: a systematic review

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

PACE: a specialised service for young people at risk of psychotic disorders

PM396. Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

Premorbid adjustment and remission of positive symptoms in first-episode psychosis ⬇️

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

Review: limited evidence from two small trials suggests no improvement in ASD symptoms with short term ω-3 supplementation ⬇️

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

The New York high-risk project: social and general intelligence in children at risk for schizophrenia ⬇️

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

Whither the attenuated psychosis syndrome?